Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
The HbA1c reductions demonstrated in the SURPASS trials (up to 2.4% reduction) were achieved with injectable administration under controlled conditions
On July 23-24, 2026, the PCAC voted to recommend BPC-157, KPV, MOTS-c,TB-500, Epitalon and Semax for inclusion on the 503A Bulks List
Furthermore, we do not recommend injections to be carried out into the tendon itself
Solutions for Chronic Inflammation with GLOW Peptide Therapy: The GLOW Peptide protocol directly targets this inflammatory cascade
TB-500 is a fragment of the full-length thymosin beta-4 (43 amino acids), and the full-length TB-4 has substantially more human safety data than the fragment
US$ 22.68
US$ 27.57
US$ 27.50
